Variant report
Variant | esv2476373 |
---|---|
Chromosome Location | chr21:28836748-28838334 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540012118 | chr21:28836755-28836756 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538568665 | chr21:28836756-28836757 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376832544 | chr21:28836811-28836812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558703812 | chr21:28836829-28836830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149718139 | chr21:28836848-28836849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs242336 | chr21:28836862-28836863 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs117805468 | chr21:28837029-28837030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182271491 | chr21:28837038-28837039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115229864 | chr21:28837043-28837044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112533668 | chr21:28837102-28837103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537847161 | chr21:28837137-28837138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553131933 | chr21:28837157-28837158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573442392 | chr21:28837158-28837159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545297712 | chr21:28837175-28837176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs242337 | chr21:28837297-28837298 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs575447023 | chr21:28837313-28837314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144637905 | chr21:28837315-28837316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542092785 | chr21:28837357-28837358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553713905 | chr21:28837406-28837407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572219457 | chr21:28837452-28837453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190841109 | chr21:28837489-28837490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370528786 | chr21:28837562-28837563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540187295 | chr21:28837589-28837590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2830959 | chr21:28837629-28837630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148477586 | chr21:28837737-28837738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376450831 | chr21:28837803-28837804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551726610 | chr21:28837804-28837805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552516663 | chr21:28837805-28837806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78939477 | chr21:28837820-28837821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34027655 | chr21:28837821-28837822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569210792 | chr21:28837842-28837843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531512928 | chr21:28837856-28837857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567739712 | chr21:28837888-28837889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367622230 | chr21:28837972-28837973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536355494 | chr21:28837980-28837981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553284194 | chr21:28838064-28838065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183394628 | chr21:28838101-28838102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373077715 | chr21:28838124-28838125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531688919 | chr21:28838138-28838139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13051499 | chr21:28838159-28838160 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs188227311 | chr21:28838178-28838179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544394788 | chr21:28838198-28838199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554875950 | chr21:28838219-28838220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574429645 | chr21:28838232-28838233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539977521 | chr21:28838253-28838254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374576567 | chr21:28838260-28838261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34458666 | chr21:28838331-28838332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 18160780 | CNVD |
Mental retardation | 17621639 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:28835200-28837000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr21:28835800-28836800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr21:28836400-28837600 | Enhancers | NHEK | skin |
4 | chr21:28836800-28837800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr21:28837800-28838600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |